Zhi-Chao Gan

  • Citations Per Year
Learn More
BACKGROUND The non-invasive identification of epidermal growth factor receptor (EGFR) mutations is important for the institution of individualized therapy of non-small cell lung cancer (NSCLC). In this study, the feasibility of screening for EGFR exon 19 E746_A750del mutations in circulating DNA from plasma was assessed. METHODS Mutant-specific primers(More)
  • 1